These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Upregulation of myocardial estrogen receptors in human aortic stenosis. Nordmeyer J; Eder S; Mahmoodzadeh S; Martus P; Fielitz J; Bass J; Bethke N; Zurbrügg HR; Pregla R; Hetzer R; Regitz-Zagrosek V Circulation; 2004 Nov; 110(20):3270-5. PubMed ID: 15533858 [TBL] [Abstract][Full Text] [Related]
24. Short-term hemodynamic effect of angiotensin-converting enzyme inhibition in patients with severe aortic stenosis: a placebo-controlled, randomized study. Dalsgaard M; Iversen K; Kjaergaard J; Grande P; Goetze JP; Clemmensen P; Hassager C Am Heart J; 2014 Feb; 167(2):226-34. PubMed ID: 24439984 [TBL] [Abstract][Full Text] [Related]
25. Effects of angiotensin converting enzyme inhibitors in hypertensive patients with aortic valve stenosis: a drug withdrawal study. Jiménez-Candil J; Bermejo J; Yotti R; Cortina C; Moreno M; Cantalapiedra JL; García-Fernández MA Heart; 2005 Oct; 91(10):1311-8. PubMed ID: 16162624 [TBL] [Abstract][Full Text] [Related]
26. Effect of bisphosphonates on the progression of degenerative aortic stenosis. Innasimuthu AL; Katz WE Echocardiography; 2011 Jan; 28(1):1-7. PubMed ID: 20678125 [TBL] [Abstract][Full Text] [Related]
27. Impact of hypertension and renin-angiotensin system inhibitors in aortic stenosis. Capoulade R; Clavel MA; Mathieu P; Côté N; Dumesnil JG; Arsenault M; Bédard E; Pibarot P Eur J Clin Invest; 2013 Dec; 43(12):1262-72. PubMed ID: 24117162 [TBL] [Abstract][Full Text] [Related]
28. [Hemodynamic effects of oral captopril in patients with critical aortic stenosis]. Martínez Sánchez C; Henne O; Arceo A; Peña M; González H; Chuquiure E; Lupi E Arch Inst Cardiol Mex; 1996; 66(4):322-30. PubMed ID: 8984953 [TBL] [Abstract][Full Text] [Related]
29. Prevention of calcific aortic valve stenosis-fact or fiction? Cawley PJ; Otto CM Ann Med; 2009; 41(2):100-8. PubMed ID: 18720096 [TBL] [Abstract][Full Text] [Related]
30. [Diphosphonates in the treatment of osteoporosis and in the prevention of associated fractures]. De Gregorio M; De Gregorio G Clin Ter; 1995 Feb; 146(2):123-32. PubMed ID: 7789073 [TBL] [Abstract][Full Text] [Related]
31. [Diphosphonates in the treatment of osteoporosis]. Papapoulos SE; Lockefeer JH Ned Tijdschr Geneeskd; 1991 Mar; 135(13):553-6. PubMed ID: 1902912 [No Abstract] [Full Text] [Related]
32. [Angiotensin-converting-enzyme inhibitor and heart hypertrophy]. Riegger AJ; Kromer EP Wien Med Wochenschr; 1990 Jan; 140(1-2):46-9. PubMed ID: 2137956 [TBL] [Abstract][Full Text] [Related]
33. [News on osteoporosis: good effect of treatment with diphosphonates]. Lakartidningen; 1997 Feb; 94(8):653-5. PubMed ID: 9072657 [No Abstract] [Full Text] [Related]
34. [Rational therapy of heart failure]. Werner MG; Schmieder RE Z Kardiol; 1993; 82 Suppl 4():7-16. PubMed ID: 8147063 [TBL] [Abstract][Full Text] [Related]
35. Bisphosphonates, statins, osteoporosis, and atherosclerosis. Watts N South Med J; 2002 Jun; 95(6):578-82. PubMed ID: 12081213 [No Abstract] [Full Text] [Related]
36. [Bisphosphonates and combined treatments osteoporosis]. Rizzoli R; Ferrari S Rev Med Suisse; 2005 Oct; 1(35):2266, 2269-71. PubMed ID: 16268449 [TBL] [Abstract][Full Text] [Related]
37. Clinical issues with bisphosphonate therapy for osteoporosis. Introduction. Siris ES Am J Med; 2009 Feb; 122(2 Suppl):S1-2. PubMed ID: 19187807 [No Abstract] [Full Text] [Related]
38. Medical therapy for calcific aortic stenosis. Salas MJ; Santana O; Escolar E; Lamas GA J Cardiovasc Pharmacol Ther; 2012 Jun; 17(2):133-8. PubMed ID: 21828284 [TBL] [Abstract][Full Text] [Related]
39. Bisphosphonate duration of therapy for management of osteoporosis. Zarowitz BJ Geriatr Nurs; 2012; 33(6):479-81. PubMed ID: 23102900 [No Abstract] [Full Text] [Related]